• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Pathog . Patterns and functional consequences of antibody speciation in maternal-fetal transfer of coronavirus-specific humoral immunity

tetano

Editor, Senior Moderator
PLoS Pathog


. 2025 Aug 6;21(8):e1013408.
doi: 10.1371/journal.ppat.1013408. Online ahead of print. Patterns and functional consequences of antibody speciation in maternal-fetal transfer of coronavirus-specific humoral immunity

Andrew P Hederman[SUP] 1 [/SUP], Hannah M Brookes[SUP] 1 [/SUP], Harini Natarajan[SUP] 2 [/SUP], Leo Heyndrickx[SUP] 3 [/SUP], Kevin K Ariën[SUP] 3 4 [/SUP], Joshua A Weiner[SUP] 1 [/SUP], Amihai Rottenstreich[SUP] 5 [/SUP], Gila Zarbiv[SUP] 6 [/SUP], Dana Wolf[SUP] 6 [/SUP], Tessa Goetghebuer[SUP] 7 8 [/SUP], Arnaud Marchant[SUP] 7 [/SUP], Margaret E Ackerman[SUP] 1 2 [/SUP]



Affiliations
Free article Abstract

Maternal antibodies serve as a temporary form of inherited immunity, providing humoral protection to vulnerable neonates. Whereas IgG is actively transferred up a concentration gradient via the neonatal Fc Receptor (FcRn), maternal IgA and IgM are typically excluded from fetal circulation. Further, not all IgG molecules exhibit the same transfer efficiency, being influenced by subclass, Fab and Fc domain glycosylation, antigen-specificity, and the temporal dynamics of maternal antibody responses. Here, we investigate the phenotypes and functions of maternal and cord blood antibodies induced by SARS-CoV-2 infection and compare them to those induced by mRNA vaccination, focusing on breadth of antigen recognition and antiviral functions including neutralization and effector function. While cord blood coronavirus-specific antibody functional breadth and potency appeared to be more compromised than binding breadth and potency in both groups, vaccination induced substantially greater function and breadth in cord blood than did natural infection. These functional phenotypes were associated with speciation of the maternal serum repertoires, as some IgG subpopulations were enriched while others were relatively depleted from cord blood. Relevant to the continued protection of vulnerable infants in the context of a diversifying pathogen, key observations included the greater breadth of antibody effector functions as compared to neutralization, which was associated with greater affinity for antigen and the more efficient placental transfer of IgG subclasses with better affinity to Fc receptors. This work provides new insights into the binding and functional breadth of inherited antibody responses that are likely responsible for the protection of infants born to seropositive mothers from severe SARS-CoV-2 infection despite continued viral diversification.


 
Back
Top Bottom